About ALSI:
We enable quantified-touch for surgical robots and medical devices
Who We Are
ALSI is the industry leader in the tactile assessment of tissue, with a specialty in bone. Our Company pioneered the field of tactile tissue measurement, developed the first practical clinical embodiment (OsteoProbe®/BoneScore®), established the reference values, and obtained FDA clearance for a new class of device. Our technology can measure materials in vivo or in situ, ‘quantifying touch’ or providing real-time tactile feedback.
Our Story
ALSI is a medical technology company founded on the work by physicist Dr. Paul Hansma of UCSB. He discovered a ‘glue-like’ role played by tiny molecular structures to dramatically improve the strength of certain materials. One such material was bone, where Dr. Hansma’s ‘bone glue’ breakthrough motivated his invention of a new way to measure the strength and quality of materials, called Reference Point Indentation (RPI).
The RPI platform enables quantified-touch for surgeons and physicians. BoneScore®, the first FDA cleared (De Novo) tactile assessment of bone, was the seminal medical device derivative of the RPI platform.
Advisors
Our board of directors and advisors are dedicated to helping ensure the Company operates in a legal, ethical, and socially responsible manner. It’s composed of individuals who are ready to significantly contribute to the overall conduct and direction of the business.
Peter Burks, PhD
Chief Executive Officer
Matt Harris, MBA
Chief Financial Officer
Alexander Proctor
Chief Technology Officer
Adolfo Diez-Perez
Chairman
Erik Eriksen
Sundeep Khosla
Jeffry Nyman
Socrates Papapoulous
Simon Tang
Natasha Appelman-Dijkstra
Linda Heller
Chairman
Bill Casner
Steven Dorfman
Harlan Levine, M.D.
